Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImperial Innovations Group Share News (IVO)

  • There is currently no data for IVO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Imperial Innovations Portfolio Value Rises, First Half Loss Narrows

Thu, 07th Apr 2016 06:49

LONDON (Alliance News) - Technology investment company Imperial Innovations Group PLC Thursday reported a narrowed pretax loss for its first half, and a rise in the value of its net portfolio.

The company invested GBP27.5 million in 17 companies in the half year to end-January, and its net portfolio value increased by GBP27.9 million to GBP355.1 million from GBP327.2 million at the end of its previous financial year.

For the half year the company reported a pretax loss of GBP5.9 million, narrowed from a pretax loss of GBP7.5 million a year before, mostly as a result of a GBP499,000 gain from the change of the fair value of its investments, compared to a GBP7.6 million loss the year before. Revenue declined to GBP2.2 million from GBP2.8 million.

Imperial Innovations' quoted portfolio includes four companies, Circassia Pharmaceuticals PLC, Abzena PLC, Oxford Immunotec Global PLC and Ixico PLC, and was valued at GBP100.0 million at the end of the half year, down from GBP106.8 million at the end of July.

Imperial Innovations said it remains confident that there is potential for a number of companies from its maturing portfolio to generate "significant returns", and it continues to see a "healthy stream of new investment opportunities."

"Overall, we have continued to deploy our capital at speed, investing GBP27.5 million across 17 companies, including GBP10.0 million invested in the new additions in the period. Collectively the portfolio has raised GBP76.0 million of total investment in the first six months of the year," said Chairman Martin Knight in a statement.

"We now have GBP238.6 million available for investment and operations, which puts us in a very strong position with ample capital to continue to scale investment within our maturing portfolio as well as maximise the opportunities expected from the new alliances with UCL Technology Fund and Apollo Therapeutics," Knight added.

By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
24 Sep 2021 11:10

AIM WINNERS & LOSERS: In The Style shares shredded by profit warning

AIM WINNERS & LOSERS: In The Style shares shredded by profit warning

Read more
5 Jan 2017 16:45

Imperial Innovations completes quick-change to Touchstone

(ShareCast News) - Imperial Innovations Group announced on Thursday that, further to the shareholder approval received at its AGM on 21 November 2016, the change of the company's name to Touchstone Innovations took effect on 4 January. The AIM-traded firm added that, with effect from 0800 GMT on Thu

Read more
28 Oct 2016 14:18

Imperial Innovations to change name to 'Touchstone'

(ShareCast News) - Imperial Innovations Group announced on Friday that at its annual general meeting on 21 November, it will be seeking shareholder approval to change the name of the company to Touchstone Innovations. The AIM-traded group was originally formed as the technology transfer office for I

Read more
24 Oct 2016 15:04

Imperial Innovations celebrates investment momentum

(ShareCast News) - Imperial Innovations Group noted on Monday that its portfolio company, Veryan Medical, has completed enrolment into the MIMICS-2 clinical study of its BioMimics 3D Self-Expanding Stent System. The AIM-traded firm said the MIMICS-2 study is a prospective, multicentre, interventiona

Read more
24 Oct 2016 06:59

Imperial Innovations Says Veryan Completes Clinical Study Enrolment

Read more
13 Oct 2016 08:36

Imperial Innovations' increases investments as pre-tax loss widens

(ShareCast News) - Imperial Innovations' annual pre-tax loss widened while the technology commercialisation and investment company increased investments across its business with universities and a joint venture. For the year ended 31 July, the pre-tax loss widened to £63.1m from £15.1m, last year, w

Read more
6 Oct 2016 15:15

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
6 Oct 2016 15:15

Imperial Innovations shares up on portfolio company progress

(ShareCast News) - Imperial Innovations Group updated the market on Thursday, noting that its portfolio company TopiVert Pharma has announced that the first patients have been dosed in its Phase IIa proof-of-concept study to evaluate the safety, tolerability and efficacy of a rectal formulation of T

Read more
6 Oct 2016 06:31

Imperial Innovations: Topivert Moves To Phase Two Of TOP1288 Study

Read more
3 Oct 2016 15:20

Imperial Innovations sells Permasense portfolio business

(ShareCast News) - AIM-listed Imperial Innovations has sold its portfolio company Permasense to Fortune 500 company Emerson Electric for an initial consideration of £30.6m in cash. Further amounts of up to £10m may be paid in addition, subject to the Permasense business achieving certain performance

Read more
21 Sep 2016 12:23

Imperial Innovations invests £5.1m in new biotech start-up

(ShareCast News) - AIM-listed technology investor Imperial Innovations invested £5.1m in Artios Pharma, a new biotech start-up launched on Wednesday. Imperial Innovations contributed £5.1m to the £25m series A funding round, giving it a 14.9% interest in the new Cambridge- based company. Artios, wh

Read more
19 Aug 2016 09:23

Cambridge University innovation investor raises 75 million pounds

LONDON, Aug 19 (Reuters) - Cambridge Innovation Capital, which commercializes technology and healthcare research from Cambridge University, has raised 75 million pounds ($98 million) from investors, including for the first time Woodford Investment Management. CIC, founded in 2013, has alrea

Read more
12 Jul 2016 06:55

Imperial Innovations Notes Cell Medica Acquisition Of Delenex

Read more
6 Jul 2016 06:41

Imperial Innovations Takes Part In New Funding For Econic Technologies

Read more
30 Jun 2016 11:39

Imperial Innovations Says PsiOxus Signs Deal With Bristol-Myers Squibb

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.